These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2273462)

  • 1. Pharmacokinetics of physostigmine intramuscularly administered to guinea pigs.
    Lukey BJ; Parrish JH; Marlow DD; Clark CR; Sidell FR
    J Pharm Sci; 1990 Sep; 79(9):796-8. PubMed ID: 2273462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a new radiometric high-performance liquid chromatographic assay to define physostigmine pharmacokinetics in guinea pigs.
    Lukey BJ; Marlow DD; Clark CR; McCluskey MP; Lieske CN
    J Chromatogr; 1989 Aug; 493(1):117-24. PubMed ID: 2778001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration.
    Somani SM
    Biopharm Drug Dispos; 1989; 10(2):187-203. PubMed ID: 2706318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of hydromorphone hydrochloride after intravenous and intramuscular administration in guinea pigs (
    Ambros B; Knych HK; Sadar MJ
    Am J Vet Res; 2020 Apr; 81(4):361-366. PubMed ID: 32228262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of diazepam intramuscularly administered to rhesus monkeys.
    Lukey BJ; Corcoran KD; Solana RP
    J Pharm Sci; 1991 Oct; 80(10):918-21. PubMed ID: 1783998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of single-dose cefmetazole following intramuscular administration of cefmetazole sodium to healthy male volunteers.
    Ko H; Novak E; Peters GR; Bothwell WM; Hosley JD; Closson SK; Adams WJ
    Antimicrob Agents Chemother; 1989 Apr; 33(4):508-12. PubMed ID: 2729944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and pharmacokinetics of physostigmine in rat after intramuscular administration.
    Somani SM; Khalique A
    Fundam Appl Toxicol; 1986 Feb; 6(2):327-34. PubMed ID: 3699321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of physostigmine after intravenous, intramuscular and subcutaneous administration in surgical patients.
    Hartvig P; Wiklund L; Lindström B
    Acta Anaesthesiol Scand; 1986 Feb; 30(2):177-82. PubMed ID: 3705906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after intravenous administration.
    Somani SM; Khalique A
    Drug Metab Dispos; 1987; 15(5):627-33. PubMed ID: 2891478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
    Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
    J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning.
    Wetherell JR
    J Pharm Pharmacol; 1994 Dec; 46(12):1023-8. PubMed ID: 7714714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of physostigmine after intravenous administration in beagle dogs.
    Giacobini E; Somani S; McIlhany M; Downen M; Hallak M
    Neuropharmacology; 1987 Jul; 26(7B):831-6. PubMed ID: 3658115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and application of a radioimmunoassay for physostigmine.
    Meyer HG; Lukey BJ; Gepp RT; McCluskey MP; Lieske CN
    J Pharmacol Exp Ther; 1989 Nov; 251(2):606-11. PubMed ID: 2810113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the decarbamoylation rates of physostigmine-inhibited plasma and red cell cholinesterases of man with other species.
    Wetherell JR; French MC
    Biochem Pharmacol; 1991 Jul; 42(3):515-20. PubMed ID: 1907148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of 4-aminopyridine in awake guinea pigs.
    Capacio BR; Chang FC; Spriggs D; Byers CE; Matthews RL; Benton BJ
    Drug Chem Toxicol; 1997 Aug; 20(3):151-72. PubMed ID: 9292275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of isoforskolin after administration via different routes in guinea pigs.
    Feng T; Li Y; Chen J; Chen Y; Huang J; Weng W
    Xenobiotica; 2016 Jul; 46(7):620-626. PubMed ID: 26523445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of physostigmine in man following a single application of a transdermal system.
    Walter K; Müller M; Barkworth MF; Nieciecki AV; Stanislaus F
    Br J Clin Pharmacol; 1995 Jan; 39(1):59-63. PubMed ID: 7756100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in Teddy goats.
    Iqbal Z; Javed I; Basit A; Jan I; Khan AA
    Pak J Pharm Sci; 2011 Jan; 24(1):69-74. PubMed ID: 21190922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for determining 4-aminopyridine in plasma: pharmacokinetics in anaesthetized guinea pigs after intravenous administration.
    Capacio BR; Byers CE; Matthews RL; Chang FC
    Biomed Chromatogr; 1996; 10(3):111-6. PubMed ID: 8792860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HI-6 pharmacokinetics in rabbits after intravenous and intramuscular administration.
    Lukey BJ; Woodard CL; Clark CR; McCluskey MP
    J Pharm Pharmacol; 1992 Aug; 44(8):690-2. PubMed ID: 1359099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.